摘要 |
The present invention relates to a pharmaceutical composition for suppressing DNA methyltransferase, containing the aryloxyacetyl-based compounds expressed in chemical formula 1 as active ingredients. The composition of the present invention can be used as a therapeutic agent for tumors, neurological brain diseases, hematologic diseases, and epigenetic diseases caused by DNA hypermethylation. Further, the present invention provides uses of aryloxyacetyl-based compounds expressed in chemical formula (1) mentioned below or pharmaceutically acceptable salts thereof to produce a DNA methyltransferase inhibitor or a DNA methylation inhibitor. The present invention provides a method for treating diseases caused by DNA hypermethylation by administering aryloxyacetyl-based compounds (LW6) expressed in chemical formula 1, or pharmaceutically acceptable salts thereof, to mammals (including humans) that require DNA methytransferase inhibition or DNA methylation inhibition. |
申请人 |
KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY;LEE, KYEONG;WON, MISUN;LEE, JUNG JOON;CHUNG, KYUNG-SOOK;PARK, SONG-KYU;KWON, BYOUNG-MOG;YIM, NAM-HUI;KANG, JUNG EUN;JIN, YINGLAN;XIA, YAN;KIM, BO YEON;AHN, JONG SEOG |
发明人 |
LEE, KYEONG;WON, MISUN;LEE, JUNG JOON;CHUNG, KYUNG-SOOK;PARK, SONG-KYU;KWON, BYOUNG-MOG;YIM, NAM-HUI;KANG, JUNG EUN;JIN, YINGLAN;XIA, YAN;KIM, BO YEON;AHN, JONG SEOG |